OWENS & MINOR INC (OMI)
US6907321029 - Common Stock
We assign a fundamental rating of 4 out of 10 to OMI. OMI was compared to 116 industry peers in the Health Care Providers & Services industry. OMI has a medium profitability rating, but doesn't score so well on its financial health evaluation. A decent growth rate in combination with a cheap valuation! Better keep an eye on OMI.
1. Profitability
1.1 Basic Checks
In the past year OMI was profitable.
OMI had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: OMI reported negative net income in multiple years.
In the past 5 years OMI always reported a positive cash flow from operatings.
1.2 Ratios
The Return On Assets of OMI (-0.74%) is comparable to the rest of the industry.
With a Return On Equity value of -4.33%, OMI perfoms like the industry average, outperforming 54.70% of the companies in the same industry.
With a decent Return On Invested Capital value of 8.01%, OMI is doing good in the industry, outperforming 77.78% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for OMI is in line with the industry average of 8.79%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.74% | ||
| ROE | -4.33% | ||
| ROIC | 8.01% |
ROA(3y)1.96%
ROA(5y)1.01%
ROE(3y)7.17%
ROE(5y)2.44%
ROIC(3y)8.85%
ROIC(5y)7.96%
1.3 Margins
The Operating Margin of OMI (3.18%) is comparable to the rest of the industry.
In the last couple of years the Operating Margin of OMI has grown nicely.
OMI has a Gross Margin of 20.75%. This is in the lower half of the industry: OMI underperforms 62.39% of its industry peers.
OMI's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 3.18% | ||
| PM (TTM) | N/A | ||
| GM | 20.75% |
OM growth 3Y3.01%
OM growth 5Y19.46%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.84%
GM growth 5Y12.59%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), OMI is creating some value.
OMI has more shares outstanding than it did 1 year ago.
OMI has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, OMI has an improved debt to assets ratio.
2.2 Solvency
OMI has a debt to FCF ratio of 6.66. This is a slightly negative value and a sign of low solvency as OMI would need 6.66 years to pay back of all of its debts.
OMI's Debt to FCF ratio of 6.66 is fine compared to the rest of the industry. OMI outperforms 72.65% of its industry peers.
OMI has a Debt/Equity ratio of 2.17. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 2.17, OMI is not doing good in the industry: 70.09% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.17 | ||
| Debt/FCF | 6.66 | ||
| Altman-Z | N/A |
ROIC/WACC1.04
WACC7.7%
2.3 Liquidity
OMI has a Current Ratio of 1.16. This is a normal value and indicates that OMI is financially healthy and should not expect problems in meeting its short term obligations.
OMI's Current ratio of 1.16 is on the low side compared to the rest of the industry. OMI is outperformed by 65.81% of its industry peers.
A Quick Ratio of 0.56 indicates that OMI may have some problems paying its short term obligations.
OMI has a Quick ratio of 0.56. This is amonst the worse of the industry: OMI underperforms 82.91% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.16 | ||
| Quick Ratio | 0.56 |
3. Growth
3.1 Past
OMI shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by 0.00%.
OMI shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 3.23% yearly.
OMI shows a small growth in Revenue. In the last year, the Revenue has grown by 3.50%.
The Revenue has been growing slightly by 1.87% on average over the past years.
EPS 1Y (TTM)0%
EPS 3Y-14.68%
EPS 5Y3.23%
EPS growth Q2Q280%
Revenue 1Y (TTM)3.5%
Revenue growth 3Y6.81%
Revenue growth 5Y1.87%
Revenue growth Q2Q3.56%
3.2 Future
The Earnings Per Share is expected to grow by 20.07% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 3.36% on average over the next years.
EPS Next Y16.38%
EPS Next 2Y21.13%
EPS Next 3Y20.72%
EPS Next 5Y20.07%
Revenue Next Year3.05%
Revenue Next 2Y2.93%
Revenue Next 3Y2.98%
Revenue Next 5Y3.36%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 12.41 indicates a correct valuation of OMI.
Based on the Price/Earnings ratio, OMI is valued cheaply inside the industry as 91.45% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of OMI to the average of the S&P500 Index (28.60), we can say OMI is valued rather cheaply.
A Price/Forward Earnings ratio of 9.33 indicates a reasonable valuation of OMI.
94.02% of the companies in the same industry are more expensive than OMI, based on the Price/Forward Earnings ratio.
OMI is valuated cheaply when we compare the Price/Forward Earnings ratio to 20.15, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.41 | ||
| Fwd PE | 9.33 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of OMI indicates a rather cheap valuation: OMI is cheaper than 95.73% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of OMI indicates a rather cheap valuation: OMI is cheaper than 96.58% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 4.41 | ||
| EV/EBITDA | 5.36 |
4.3 Compensation for Growth
OMI's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
OMI's earnings are expected to grow with 20.72% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.76
PEG (5Y)3.84
EPS Next 2Y21.13%
EPS Next 3Y20.72%
5. Dividend
5.1 Amount
No dividends for OMI!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
OWENS & MINOR INC
NYSE:OMI (5/17/2024, 7:17:50 PM)
After market: 18.62 0 (0%)18.62
-0.49 (-2.56%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap1.43B
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.41 | ||
| Fwd PE | 9.33 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)0.76
PEG (5Y)3.84
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.74% | ||
| ROE | -4.33% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | 3.18% | ||
| PM (TTM) | N/A | ||
| GM | 20.75% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover2
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.17 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 1.16 | ||
| Quick Ratio | 0.56 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)0%
EPS 3Y-14.68%
EPS 5Y
EPS growth Q2Q
EPS Next Y16.38%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)3.5%
Revenue growth 3Y6.81%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y